caffeine and carboplatin

caffeine has been researched along with carboplatin in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (66.67)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Botet, J; Casper, E; Dougherty, J; Hudis, C; Kelsen, D; Niedzwiecki, D; Rosenbluth, R; Vinciguerra, V	1
Efferth, T; Fabry, U; Glatte, P; Osieka, R	1
Chen, SY; Kussick, SJ; Roberson, RS; Vallieres, E; Wu, DY	1

Trials

1 trial(s) available for caffeine and carboplatin

Article	Year
A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma. Cancer, 1991, Sep-01, Volume: 68, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycins; Pancreatic Neoplasms; Streptozocin	1991

Article

Year

A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.

Cancer, 1991, Sep-01, Volume: 68, Issue:5

Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Caffeine; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycins; Pancreatic Neoplasms; Streptozocin

1991

Other Studies

2 other study(ies) available for caffeine and carboplatin

Article	Year
Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells. Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:11 Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; G2 Phase; Gamma Rays; Gene Expression Regulation, Leukemic; Glutathione; GTP-Binding Proteins; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Multivariate Analysis; Oncogene Proteins v-fos; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; ras Proteins; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1995
Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers. Cancer research, 2005, Apr-01, Volume: 65, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Caffeine; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Division; Cell Line, Tumor; Cellular Senescence; G2 Phase; Humans; Lung Neoplasms; Neoadjuvant Therapy; Paclitaxel; Randomized Controlled Trials as Topic; Research Support as Topic; RNA, Small Interfering; Transcription, Genetic; Tumor Suppressor Protein p53	2005

Article

Year

Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.

Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:11

Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; G2 Phase; Gamma Rays; Gene Expression Regulation, Leukemic; Glutathione; GTP-Binding Proteins; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Multivariate Analysis; Oncogene Proteins v-fos; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; ras Proteins; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1995

Escape from therapy-induced accelerated cellular senescence in p53-null lung cancer cells and in human lung cancers.

Cancer research, 2005, Apr-01, Volume: 65, Issue:7

Topics: Antineoplastic Combined Chemotherapy Protocols; Caffeine; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; CDC2 Protein Kinase; Cell Division; Cell Line, Tumor; Cellular Senescence; G2 Phase; Humans; Lung Neoplasms; Neoadjuvant Therapy; Paclitaxel; Randomized Controlled Trials as Topic; Research Support as Topic; RNA, Small Interfering; Transcription, Genetic; Tumor Suppressor Protein p53

2005